Tetrahydroquinoline derivatives and use of same for treating cancer

Details for Australian Patent Application No. 2008228570 (hide)

Owner Merck Patent GmbH

Inventors Finsinger, Dirk; Schiemann, Kai; Zenke, Frank; Amendt, Christiane

Agent Davies Collison Cave

Pub. Number AU-A-2008228570

PCT Pub. Number WO2008/113456

Priority 10 2007 013 854.9 20.03.07 DE

Filing date 22 February 2008

Wipo publication date 25 September 2008

International Classifications

C07D 495/14 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/436 (2006.01)

A61K 31/4365 (2006.01)

A61K 31/437 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 491/147 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

26 November 2009 PCT application entered the National Phase

  PCT publication WO2008/113456 Priority application(s): WO2008/113456

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008228596-Method and device for fired intermediate overheating during direct solar vapourisation in a solar thermal power station

2008228566-Substituted tetrahydropyrroloquinolines